[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States RNAi for Therapeutic Market Report 2016

October 2016 | 123 pages | ID: UDF39324997EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of RNAi for Therapeutic

Revenue, means the sales value of RNAi for Therapeutic

This report studies sales (consumption) of RNAi for Therapeutic in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Alnylam Pharmaceuticals
  • Arbutus Biopharma (Tekmira)
  • Arrowhead Research
  • Dicerna Pharmaceuticals
  • Mirna Therapeutics
  • Quark Pharmaceuticals
  • RXi Pharmaceuticals
  • Silence Therapeutics
  • Benitec Biopharma
  • Miragen Therapeutics
  • Sylentis
  • Gradalis
  • Sirnaomics
  • Silenseed
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • siRNA
  • miRNA
  • shRNA
Split by applications, this report focuses on sales, market share and growth rate of RNAi for Therapeutic in each application, can be divided into
  • Cancer
  • Cardiovascular
  • HBV
United States RNAi for Therapeutic Market Report 2016

1 RNAI FOR THERAPEUTIC OVERVIEW

1.1 Product Overview and Scope of RNAi for Therapeutic
1.2 Classification of RNAi for Therapeutic
  1.2.1 siRNA
  1.2.2 miRNA
  1.2.3 shRNA
1.3 Application of RNAi for Therapeutic
  1.3.1 Cancer
  1.3.2 Cardiovascular
  1.3.3 HBV
1.4 USA Market Size Sales (Value) and Revenue (Volume) of RNAi for Therapeutic (2011-2021)
  1.4.1 USA RNAi for Therapeutic Sales and Growth Rate (2011-2021)
  1.4.2 USA RNAi for Therapeutic Revenue and Growth Rate (2011-2021)

2 USA RNAI FOR THERAPEUTIC COMPETITION BY MANUFACTURERS

2.1 USA RNAi for Therapeutic Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA RNAi for Therapeutic Revenue and Share by Manufactures (2015 and 2016)
2.3 USA RNAi for Therapeutic Average Price by Manufactures (2015 and 2016)
2.4 RNAi for Therapeutic Market Competitive Situation and Trends
  2.4.1 RNAi for Therapeutic Market Concentration Rate
  2.4.2 RNAi for Therapeutic Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 USA RNAI FOR THERAPEUTIC SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 USA RNAi for Therapeutic Sales and Market Share by Type (2011-2016)
3.2 USA RNAi for Therapeutic Revenue and Market Share by Type (2011-2016)
3.3 USA RNAi for Therapeutic Price by Type (2011-2016)
3.4 USA RNAi for Therapeutic Sales Growth Rate by Type (2011-2016)

4 USA RNAI FOR THERAPEUTIC SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 USA RNAi for Therapeutic Sales and Market Share by Application (2011-2016)
4.2 USA RNAi for Therapeutic Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 USA RNAI FOR THERAPEUTIC MANUFACTURERS PROFILES/ANALYSIS

5.1 Alnylam Pharmaceuticals
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 RNAi for Therapeutic Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Arbutus Biopharma (Tekmira)
  5.2.2 RNAi for Therapeutic Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Arrowhead Research
  5.3.2 RNAi for Therapeutic Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Arrowhead Research RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Dicerna Pharmaceuticals
  5.4.2 RNAi for Therapeutic Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Dicerna Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Mirna Therapeutics
  5.5.2 RNAi for Therapeutic Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Mirna Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Quark Pharmaceuticals
  5.6.2 RNAi for Therapeutic Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Quark Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 RXi Pharmaceuticals
  5.7.2 RNAi for Therapeutic Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 RXi Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Silence Therapeutics
  5.8.2 RNAi for Therapeutic Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Silence Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Benitec Biopharma
  5.9.2 RNAi for Therapeutic Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Benitec Biopharma RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Miragen Therapeutics
  5.10.2 RNAi for Therapeutic Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Miragen Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Sylentis
5.12 Gradalis
5.13 Sirnaomics
5.14 Silenseed

6 RNAI FOR THERAPEUTIC MANUFACTURING COST ANALYSIS

6.1 RNAi for Therapeutic Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of RNAi for Therapeutic

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 RNAi for Therapeutic Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of RNAi for Therapeutic Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 USA RNAI FOR THERAPEUTIC MARKET FORECAST (2016-2021)

10.1 USA RNAi for Therapeutic Sales, Revenue Forecast (2016-2021)
10.2 USA RNAi for Therapeutic Sales Forecast by Type (2016-2021)
10.3 USA RNAi for Therapeutic Sales Forecast by Application (2016-2021)
10.4 RNAi for Therapeutic Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of RNAi for Therapeutic
Table Classification of RNAi for Therapeutic
Figure USA Sales Market Share of RNAi for Therapeutic by Type in 2015
Figure siRNA Picture
Figure miRNA Picture
Figure shRNA Picture
Table Application of RNAi for Therapeutic
Figure USA Sales Market Share of RNAi for Therapeutic by Application in 2015
Figure Cancer Examples
Figure Cardiovascular Examples
Figure HBV Examples
Figure USA RNAi for Therapeutic Sales and Growth Rate (2011-2021)
Figure USA RNAi for Therapeutic Revenue and Growth Rate (2011-2021)
Table USA RNAi for Therapeutic Sales of Key Manufacturers (2015 and 2016)
Table USA RNAi for Therapeutic Sales Share by Manufacturers (2015 and 2016)
Figure 2015 RNAi for Therapeutic Sales Share by Manufacturers
Figure 2016 RNAi for Therapeutic Sales Share by Manufacturers
Table USA RNAi for Therapeutic Revenue by Manufacturers (2015 and 2016)
Table USA RNAi for Therapeutic Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA RNAi for Therapeutic Revenue Share by Manufacturers
Table 2016 USA RNAi for Therapeutic Revenue Share by Manufacturers
Table USA Market RNAi for Therapeutic Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market RNAi for Therapeutic Average Price of Key Manufacturers in 2015
Figure RNAi for Therapeutic Market Share of Top 3 Manufacturers
Figure RNAi for Therapeutic Market Share of Top 5 Manufacturers
Table USA RNAi for Therapeutic Sales by Type (2011-2016)
Table USA RNAi for Therapeutic Sales Share by Type (2011-2016)
Figure USA RNAi for Therapeutic Sales Market Share by Type in 2015
Table USA RNAi for Therapeutic Revenue and Market Share by Type (2011-2016)
Table USA RNAi for Therapeutic Revenue Share by Type (2011-2016)
Figure Revenue Market Share of RNAi for Therapeutic by Type (2011-2016)
Table USA RNAi for Therapeutic Price by Type (2011-2016)
Figure USA RNAi for Therapeutic Sales Growth Rate by Type (2011-2016)
Table USA RNAi for Therapeutic Sales by Application (2011-2016)
Table USA RNAi for Therapeutic Sales Market Share by Application (2011-2016)
Figure USA RNAi for Therapeutic Sales Market Share by Application in 2015
Table USA RNAi for Therapeutic Sales Growth Rate by Application (2011-2016)
Figure USA RNAi for Therapeutic Sales Growth Rate by Application (2011-2016)
Table Alnylam Pharmaceuticals Basic Information List
Table Alnylam Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Alnylam Pharmaceuticals RNAi for Therapeutic Sales Market Share (2011-2016)
Table Arbutus Biopharma (Tekmira) Basic Information List
Table Arbutus Biopharma (Tekmira) RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Arbutus Biopharma (Tekmira) RNAi for Therapeutic Sales Market Share (2011-2016)
Table Arrowhead Research Basic Information List
Table Arrowhead Research RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Arrowhead Research RNAi for Therapeutic Sales Market Share (2011-2016)
Table Dicerna Pharmaceuticals Basic Information List
Table Dicerna Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dicerna Pharmaceuticals RNAi for Therapeutic Sales Market Share (2011-2016)
Table Mirna Therapeutics Basic Information List
Table Mirna Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mirna Therapeutics RNAi for Therapeutic Sales Market Share (2011-2016)
Table Quark Pharmaceuticals Basic Information List
Table Quark Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Quark Pharmaceuticals RNAi for Therapeutic Sales Market Share (2011-2016)
Table RXi Pharmaceuticals Basic Information List
Table RXi Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table RXi Pharmaceuticals RNAi for Therapeutic Sales Market Share (2011-2016)
Table Silence Therapeutics Basic Information List
Table Silence Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Silence Therapeutics RNAi for Therapeutic Sales Market Share (2011-2016)
Table Benitec Biopharma Basic Information List
Table Benitec Biopharma RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Benitec Biopharma RNAi for Therapeutic Sales Market Share (2011-2016)
Table Miragen Therapeutics Basic Information List
Table Miragen Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Miragen Therapeutics RNAi for Therapeutic Sales Market Share (2011-2016)
Table Sylentis Basic Information List
Table Sylentis RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sylentis RNAi for Therapeutic Sales Market Share (2011-2016)
Table Gradalis Basic Information List
Table Gradalis RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gradalis RNAi for Therapeutic Sales Market Share (2011-2016)
Table Sirnaomics Basic Information List
Table Sirnaomics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sirnaomics RNAi for Therapeutic Sales Market Share (2011-2016)
Table Silenseed Basic Information List
Table Silenseed RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Silenseed RNAi for Therapeutic Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of RNAi for Therapeutic
Figure Manufacturing Process Analysis of RNAi for Therapeutic
Figure RNAi for Therapeutic Industrial Chain Analysis
Table Raw Materials Sources of RNAi for Therapeutic Major Manufacturers in 2015
Table Major Buyers of RNAi for Therapeutic
Table Distributors/Traders List
Figure USA RNAi for Therapeutic Production and Growth Rate Forecast (2016-2021)
Figure USA RNAi for Therapeutic Revenue and Growth Rate Forecast (2016-2021)
Table USA RNAi for Therapeutic Production Forecast by Type (2016-2021)
Table USA RNAi for Therapeutic Consumption Forecast by Application (2016-2021)


More Publications